Mesothelioma

FDA’s Approval of Opdivo-Yervoy for Unresectable Malignant Pleural Mesothelioma was ‘Desperately Needed’, But Questions Remain

October 20th 2020, 9:00pm

The FDA’s approval or Opdivo (nivolumab) and Yervoy (ipilimumab) for the frontline treatment of patients with unresectable malignant pleural mesothelioma was desperately needed, says a thoracic oncologist at Memorial Sloan Kettering Cancer center. However, some questions remain.

FDA Approves Opdivo-Yervoy Combo for Unresectable Malignant Pleural Mesothelioma

October 2nd 2020, 8:42pm

Article

The Food and Drug Administration’s approval of Opdivo in combination with Yervoy for patients with unresectable malignant pleural mesothelioma marks the first new systemic therapy approved in more than 15 years in this setting.

CURE's Clinical Trial Corner: Mesothelioma Edition

November 25th 2019, 7:00pm

Article

Here is a list of clinical trials that are currently happening within the mesothelioma space.

Friday Frontline: Cancer Updates, Research and Education on November 22, 2019

November 22nd 2019, 9:00pm

Article

From plans to sue the School District of Philadelphia over a mesothelioma diagnosis to Dwayne “The Rock” Johnson singing for a 3-year-old with acute lymphoblastic leukemia, here’s what is making headlines in the cancer space this week.

Scientists See Potential in Cellular "Death by Iron" for Cancer Treatment

October 19th 2019, 10:00pm

Article

The same properties that make certain cancers hard to treat may also promote their death by ferroptosis, scientists at the Sloan Kettering Institute have found.

Fighting the Uncertainty of Cancer With Self-Education

October 11th 2019, 8:00pm

Article

A seven-year mesothelioma survivor encourages patients with cancer to be their own advocate.

The Role of Immunotherapy in Treating Mesothelioma

October 11th 2019, 1:00am

Article

A phase 3 trial compared Keytruda versus chemotherapy for patients with advanced pretreated malignant pleural mesothelioma.

Investigational Drug Shows Response in Patients with Malignant Pleural Mesothelioma

September 20th 2019, 10:00pm

Article

Cediranib combined with platinum-based chemotherapy helped patients live longer than placebo.

Addressing Diet and Nutrition in Patients With Mesothelioma

August 12th 2019, 10:00pm

Article

A registered dietician discussed the importance of maintaining one’s weight while going through treatment for mesothelioma.

Past, Present and Future: How Far We've Come With Mesothelioma

July 29th 2019, 7:23pm

Article

CURE® spoke with one expert about the various treatment options and current clinical trials available to patients with mesothelioma, as well as what they have to look forward to in the future.